Antiarrhythmic and haemodynamic effects of the commonly used intravenous electrolytes
1Department of Critical Care Medicine, Flinders Medical Centre, Adelaide, South Australia.
Insights
Intravenous electrolytes like potassium chloride and magnesium sulfate can effectively manage cardiac arrhythmias and improve hemodynamics. Careful administration and monitoring are crucial due to selective indications and potential complications.
Area of Science:
- Cardiovascular Physiology
- Clinical Pharmacology
- Electrolyte Imbalance
Background:
- Intravenous electrolytes are commonly administered in critical care settings.
- Understanding their physiological and cardiovascular effects is essential for safe and effective use.
- Electrolyte disturbances can significantly impact cardiac function and rhythm.
Purpose of the Study:
- To review the physiology and cardiovascular effects of commonly used intravenous electrolytes.
- To elucidate the haemodynamic and antiarrhythmic properties of various electrolyte solutions.
- To provide guidance on the therapeutic applications of intravenous electrolytes in managing cardiac conditions.
Main Methods:
- A comprehensive MEDLINE search was conducted for studies published between 1966 and 2000.
- The search focused on abstracts, articles, and reviews related to cardiac arrhythmias and electrolytes.
- Relevant literature was systematically reviewed to synthesize findings on electrolyte effects.
Main Results:
- Isotonic saline improves haemodynamics in hypotensive, hypovolaemic patients.
- Potassium chloride, calcium chloride, magnesium sulfate, phosphate, hypertonic saline, and sodium bicarbonate exhibit unique haemodynamic and antiarrhythmic effects.
- Specific electrolytes are indicated for conditions like hypokalaemia, hyperkalaemia, hypomagnesaemia, and certain toxicities, requiring careful dosing and monitoring.
Conclusions:
- Intravenous electrolytes, including potassium chloride, calcium chloride, magnesium sulfate, sodium/potassium phosphate, sodium bicarbonate, and hypertonic saline, can effectively manage cardiac arrhythmias and alter haemodynamic status.
- The use of these electrolytes is selective, and potential complications necessitate careful administration and vigilant monitoring.
- Optimizing electrolyte balance is a key strategy in managing critical cardiovascular conditions.
Objective:
To review the physiology and cardiovascular effects of the commonly used intravenous electrolytes.
Data Sources:
Abstracts, articles and published reviews of studies reported from 1966 to 2000 and identified through a MEDLINE search on cardiac arrhythmias and electrolytes.
Summary Of Review:
While isotonic saline solutions are used to improve the haemodynamic status in critically ill patients who are hypotensive and hypovolaemic, other intravenous solutions including potassium chloride, calcium chloride, magnesium sulphate and sodium or potassium phosphate as well as hypertonic saline and sodium bicabonate have unique and often therapeutically useful haemodynamic and antiarrhythmic effects. Potassium chloride solutions are used to treat hypokalaemia with a maximum speed of correction in an adult of 20 mmol per 30 minutes when an acute myocardial infarct is present. A greater infusion rate may be necessary when ventricular or supraventricular tachyarrhythmias are present although close ECG monitoring will be required. Magnesium sulphate (2-20 mmol) has been used for hypomagnesaemic and normomagnesaemic cardiac arrhythmias (particularly when digoxin induced) and calcium chloride (3.4-6.8 mmol) is used to treat hyperkalaemic and hypermagnesaemic cardiac arrhythmias. Both hypertonic sodium bicarbonate and sodium chloride solutions have antiarrhythmic effects that may be beneficial in conditions that include tricyclic poisoning, hyperkalaemia and bupivicaine toxicity, although sodium bicarbonate is generally used for tricyclic cardiotoxicity. Low cardiac output states and arrhythmias have also been reported in hypophosphataemic patients that are reversed by infusions of potassium or sodium phosphate.
Conclusions:
Intravenous potassium chloride, calcium chloride, magnesium sulphate, sodium and potassium phosphate, sodium bicarbonate and hypertonic saline can be used effectively to alter the haemodynamic status and manage cardiac arrhythmias. However, their indications are selective and complications may occur, so careful administration and monitoring are required with their use.
Related Concept Videos
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
01:26Heart Failure Drugs: Inotropic Agents
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
01:25Dysrhythmias VI: Management of Dysrhythmias